Table 4:
Implementation Strategy for intervention and control clusters.
| Activity | What | Who | When | Where | How |
|---|---|---|---|---|---|
| Intervention clusters | |||||
| Case identification | Detection of cases | Community-level health worker (CLHW) | Young infant is seen by the CLHW either at their place of work or during routine postnatal home visits | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment |
| Screening and enrolment | Detection of eligible cases | CLHW | Young infant is seen by the CLHW either at their place of work or during routine postnatal home visits | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment, pulse oximetry and consent |
| Confirmation of cases | Validation of eligible cases identified by CLHW | Study Supervisor | An eligible young infant is identified by a CLHW and supervisor is informed | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment, pulse oximetry and confirmation of CLHWs findings |
| Treatment provision | Oral amoxicillin | CLHW and parents/care givers | After enrolment and consent | First dose given at place of enrolment and remaining doses given at home | Practical demonstration of giving the first dose in front of mother/caregiver |
| Follow up | Follow up assessments of infants under intervention treatment | CLHW | On days 2,4 and 7 after enrolment | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment, pulse oximetry and checking treatment adherence |
| Supervision | Sub-sample on follow-up days for quality assurance | Study Supervisor | Follow-up visits on days 2, 4, and 7 | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Conformational assessment |
| Outcome assessment | Outcome assessment | Independent Outcome Assessor | Days 6, 14 and if patient deteriorated in between | Patients household or a hospital if patient was admitted | Clinical assessment and filling outcome assessment form |
| Control clusters | |||||
| Case identification | Detection of cases | CLHW | Young infant is seen by the CLHW either at their place of work or during routine postnatal home visits | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment |
| Screening and enrolment | Detection of eligible cases | CLHW | Young infant is seen by the CLHW either at their place of work or during routine postnatal home visits | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment, and consent |
| Confirmation of cases | Validation of eligible cases identified by CLHW | Study Supervisor | An eligible young infant is identified by a CLHW and supervisor is informed | Community clinic in Bangladesh, Health Post in Ethiopia, Household in India and Malawi | Clinical assessment, and confirmation of CLHWs findings, pulse oximetry |
| Treatment provision | Refer to a referral facility | CLHW | After enrolment and consent | First dose given at place of enrolment and refer to a referral facility | Counselling for referral |
| Follow up | NA | NA | NA | NA | NA |
| Supervision | NA | NA | NA | NA | NA |
| Outcome assessment | Outcome assessment | Independent Outcome Assessor | Days 6, 14 and if patient deteriorated in between | Patients household or a hospital if patient was admitted | Clinical assessment and filling outcome assessment form |
NA: not applicable.